Our results indicated that levels of cAMP were higher in experimental groups with steatotic livers than in those with non-steatotic ones submitted to LT and BD, and it was demonstrated (through an experiment involving inhibition of IL-1β action) that IL-1β was responsible for cAMP generation in such experimental conditions. This evidence concerns the gene IL1B and Behcet disease.